Page last updated: 2024-09-05

farglitazar and 1,2,3,4-tetrahydroisoquinoline carboxylic acid

farglitazar has been researched along with 1,2,3,4-tetrahydroisoquinoline carboxylic acid in 1 studies

Compound Research Comparison

Studies
(farglitazar)
Trials
(farglitazar)
Recent Studies (post-2010)
(farglitazar)
Studies
(1,2,3,4-tetrahydroisoquinoline carboxylic acid)
Trials
(1,2,3,4-tetrahydroisoquinoline carboxylic acid)
Recent Studies (post-2010) (1,2,3,4-tetrahydroisoquinoline carboxylic acid)
35351803

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azukizawa, S; Kanda, M; Kasai, M; Kunishiro, K; Miike, T; Mukai, C; Shirahase, H; Takahashi, K1

Other Studies

1 other study(ies) available for farglitazar and 1,2,3,4-tetrahydroisoquinoline carboxylic acid

ArticleYear
Synthesis and biological evaluation of (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: a novel series of PPAR gamma agonists.
    Chemical & pharmaceutical bulletin, 2008, Volume: 56, Issue:3

    Topics: 3T3 Cells; Adipocytes; Animals; Blood Glucose; Cell Differentiation; Chemical Phenomena; Chemistry, Physical; Chromatography, Thin Layer; Cyclization; Hypoglycemic Agents; Hypolipidemic Agents; Indicators and Reagents; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Mice, Inbred ICR; Oxazoles; PPAR gamma; Rats; Rats, Sprague-Dawley; Rats, Zucker; Spectrophotometry, Infrared; Structure-Activity Relationship; Tetrahydroisoquinolines; Triglycerides; Tyrosine

2008